中国药房2023，Vol.34Issue(24)：2951-2967,17.DOI:10.6039/j.issn.1001-0408.2023.24.02
抗凝药物审方规则专家共识
Expert consensus on prescription review rules of anticoagulants
摘要
Abstract
OBJECTIVE To further standardize the clinical application of anticoagulants and provide reference for improving the efficiency of prescription review of anticoagulants in medical institutions.METHODS Initiated by the Pharmaceutical Administration Committee of Chongqing Hospital Association and led by the Second Affiliated Hospital of Chongqing Medical University,in collaboration with experts in relevant fields from multiple provinces across the country,the prescription review rules,warning levels,and intervention measures for 12 kinds of common anticoagulants were established based on drug instructions.Regarding clinical drug use that was not covered by the basic review rules,based on reference to existing guidelines and expert consensus,42 experts from 22 hospitals in 8 provinces across the country were consulted by letter to form a consensus.RESULTS&CONCLUSIONS The basic prescription review rules of 12 kinds of anticoagulants,including unfractionated heparin,enoxaparin sodium,nadroparin calcium,dalteparin sodium,fondaparinux sodium,bivalirudin,argatroban,warfarin,dabigatran etexilate,rivaroxaban,apixaban and edoxaban,had been established according to drug instruction,as well as warning levels beyond the basic review rules and corresponding intervention measures.After two rounds of expert consultation,17 recommendations for prescription review were formed regarding some clinical drug use that were not covered by the basic prescription review rules.With the progress of clinical research,this consensus will be further updated and adjusted;in addition,as this consensus does not cover all situations where anticoagulants are used in clinical practice,prescription reviewer must conduct personalized evaluations based on the specific situation of the patient.关键词
抗凝药物/处方适宜性/审方规则/临床应用/专家共识Key words
anticoagulants/prescription suitability/prescription review rules/clinical application/expert consensus分类
医药卫生引用本文复制引用
重庆市医院协会药事管理专业委员会,钱妍,赵春景..抗凝药物审方规则专家共识[J].中国药房,2023,34(24):2951-2967,17.基金项目
2023年国家临床重点专科项目(No.渝卫办发[2023]48号) （No.渝卫办发[2023]48号）
重庆医科大学附属第二医院"宽仁英才-骨干人才"项目(No.重医二院党[2022]28号) （No.重医二院党[2022]28号）
